Benchmark

Benchmark lowered its rating on PriceSmart (NASDAQ: PSMT) from Buy to Hold while raising its price target from $80 to $86. Benchmark noted, "Despite Colombia and store base continuing to show strong growth, the share price exceeded our prior price target and is in striking distance of our new...

Benchmark raised its rating on Expedia (NASDAQ: EXPE) from Hold to Buy with a new $67 price target. Benchmark said, "We are raising our rating on shares of Expedia (EXPE) from Hold to Buy as continued solid execution, strong organic tailwinds and an aggressive expansion strategy have allowed the...

Benchmark reiterated its Buy rating on Susser Holdings Corporation (NASDAQ: SUSS) and raised its price target from $42 to $47. Benchmark noted, "We believe the spin off of Susser Petroleum Partners (NYSE-SUSP) adds value to shareholders of SUSS. We increased our price target for Susser Holdings...

Benchmark raised its rating on Pep Boys (NYSE: PBY) from Hold to Buy and increased its price target from $10 to $12. Benchmark said, "We believe an improving tire profit environment and a possible debt refinance could provide catalysts for earnings improvement, despite weakness on discretionary...

Benchmark maintained its Hold rating and $25 price target on Diodes (NASDAQ: DIOD) as the company has moved to expand its presence in the general purpose analog space. Benchmark commented, "Diodes announced the acquisition of Power Analog Microelectronics (PAM), a developer of advanced analog and...

The Benchmark Company reiterated its Buy rating on American Science & Engineering (NASDAQ: ASEI) and increased its price target from $67 to $73. Benchmark commented, "Per our upgrade on August 28, we believe visibility for AS&E has significantly improved with the $34+ million ZBV service...

Benchmark reiterated its Buy rating on CBS (NYSE: CBS) and increased its price target from $39 to $40. Benchmark noted, "At a recent investor conference, CBS management stated that CBS television ad revenue growth accelerated in recent weeks, driven by political advertising. Network revenues have...

Benchmark reduced its rating on IRIS International (NASDAQ: IRIS) from Buy to Hold and raised its price target to $19.50. Benchmark said, "On September 17 IRIS International announced it has entered into a definitive agreement to be sold to Danaher Corporation (DHR: not covered) for $19.50 per...

Benchmark raised its rating on Moody's (NYSE: MCO) from Hold to Buy and increased its price target from $43 to $51. Benchmark commented, "We are raising our 2012 revenue and EPS estimates, due to a surge in bond issuance, along with strong growth prospects at Moody's Analytics. … Following a...

Benchmark initiated coverage on Haemonetics Corporation (NYSE: HAE) with a Buy rating and a price target of $89 a share. Benchmark commented, "Haemonetics is positioned to leverage a stable base of mid-single digit organic revenue growth in its blood products management businesses. Organic...

Benchmark initiated its coverage on LivePerson (NASDAQ: LPSN) with a Buy rating and a price target of $22 a share. Benchmark commented, "We are initiating coverage of LivePerson with a Buy rating, a $22 price target, and expectations the Company will earn adjusted EPS of $0.32 on $161 million in...

Benchmark raised its rating on American Science & Engineering (NASDAQ: ASEI) from Hold to Buy and established a price target of $67 a share. Benchmark commented, "Our upgrade is based on improving visibility in FY13 for both service and cargo revenues, as well as potential upside in FY13/14...

Benchmark reiterated its Buy rating on Valassis Communications (NYSE: VCI) and raised its price target from $24 to $27. Benchmark noted, "For Valassis (VCI-Buy, PT from $24 to $27), expected growth in Shared Mail, the addition of Brand.net and the benefit of restructuring and cost reduction...

Benchmark reduced its rating on Groupon (NASDAQ: GRPN) from Buy to Hold and reduced its price target from $20 to $7. Benchmark noted, "2Q12 subscriber growth slowed meaningfully. Gross billing per subscriber dropped materially. This drove gross billings down sequentially. This was discouraging...

Benchmark reiterated its Buy rating on Fossil (NASDAQ: FOSL) and raised its price target from $85 to $105. Benchmark noted, "The Company reported sales growth in all segments of its business, with sales growth accelerating from Q1 despite macro weakness in Europe and Asia. We believe this is a...